Clinical Trials Browser

Interventional × Thymus Neoplasms × 30 days × Clear all

Thymic epithelial tumor, Thymoma, Thymus Neoplasms

NCT05104736 2026-04-07

PT-112 in Subjects With Thymoma and Thymic Carcinoma

Phase 2 Recruiting

53 enrolled

Thoracic

Thymic epithelial tumor, Peripheral Nervous System Diseases, Thymoma, Thymus Neoplasms

NCT06189183 2026-04-01

Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection

Phase NA Active not recruiting

50 enrolled

Thymus Neoplasms

NCT04234113 2026-03-27

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

Phase 1 Terminated

115 enrolled 43 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Ovarian Neoplasms, Stomach Neoplasms, Thymus Neoplasms, Thyroid Neoplasms, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Clinical Trials

Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma

PT-112 in Subjects With Thymoma and Thymic Carcinoma

Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors